Astrazeneca (AZN) Revenue Growth (5y) (2014 - 2026)
Powered by 
Analysis
Astrazeneca (AZN) Revenue Growth (5y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Asml Holding | 618.78 Bn | 602.80 Bn | 5.90 Bn |
| 2 | Hsbc Holdings | 362.62 Bn | 362.62 Bn | - |
| 3 | General Electric | 329.79 Bn | 320.45 Bn | 6.95 Bn |
| 4 | Astrazeneca | 253.78 Bn | 248.49 Bn | 12.86 Bn |
| 5 | Citigroup | 228.38 Bn | -2,073.93 Bn | 24.75 Bn |
| 6 | Bhp | 216.07 Bn | 197.52 Bn | - |
| 7 | Rio Tinto | 203.71 Bn | 199.33 Bn | - |
| 8 | Diageo | 197.09 Bn | 195.06 Bn | - |
| 9 | Unilever | 139.31 Bn | 132.28 Bn | - |
| 10 | Hdfc Bank | 117.84 Bn | 80.69 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.84% |
| Mar 31, 2026 | 15.95% |
| Dec 31, 2025 | 17.19% |
| Sep 30, 2025 | 18.41% |
| Jun 30, 2025 | 19.03% |
| Mar 31, 2025 | 16.45% |
| Dec 31, 2024 | 17.63% |
| Sep 30, 2024 | 17.11% |
| Jun 30, 2024 | 17.31% |
| Mar 31, 2024 | 18.25% |
| Dec 31, 2023 | 41.28% |
| Sep 30, 2023 | 15.91% |
| Jun 30, 2023 | 16.69% |
| Mar 31, 2023 | 16.21% |
| Dec 31, 2022 | 15.35% |
| Sep 30, 2022 | 17.60% |
| Jun 30, 2022 | 16.56% |
| Mar 31, 2022 | 18.65% |
| Dec 31, 2021 | 16.93% |
| Sep 30, 2021 | 14.15% |